ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Association for the Treatment of Neuroplastic Symptoms Holds National Conference Sept. 28-30





Leading experts gather in Boulder, Colo., to explore new science for relieving nonstructural chronic pain and illness

BOULDER, CO, September 08, 2025 /24-7PressRelease/ -- Medical professionals, researchers, and mental health experts will explore the latest advances in diagnosing and treating non-structural pain and illness at the national conference of the Association for the Treatment of Neuroplastic Symptoms Sept. 28-30 in Boulder, Colo.

Neuroplastic symptoms are caused by stress-induced changes in nerve pathways in the brain, rather than by injury or illness. They include fibromyalgia, migraines, irritable bowel syndrome, chronic back pain, many cases of long COVID, and dozens more conditions.

Nearly half of US adults have pain or illness that is either unexplained or is not responding as expected to treatment, according to results of a new national survey to be presented at the conference. It is likely that symptoms in a large majority of this group are neuroplastic.

"This is the first national survey of its kind ever done, and it addresses a large range of questions affecting 40% of people who see a doctor for symptoms," says Dr. David Clarke, president of the ATNS.

The conference will feature more than 40 leading experts in neuroplastic pain and illness. Unlike conditions caused by disease or injury, these are caused by changes in neural pathways that are learned in response to stress, trauma, and adversity — often starting in childhood. When these patterns are uncovered and understood, this knowledge can lead to healing without the need for invasive procedures or long-term medical treatment.

The ATNS is a 501(c)(3) nonprofit dedicated to ending the chronic pain epidemic by promoting awareness, diagnosis, and treatment of neuroplastic pain and illness. They support an evidence-based, biopsychosocial approach called Neuroplastic Recovery Therapy that is safer, more affordable, and more effective than traditional methods in treating chronic pain. With a focus on uncovering stress, trauma, and unrecognized emotion, patients are able to take control of their symptoms without drugs, surgery, or expensive treatments.

"Neuroplastic Recovery Therapy is the only treatment backed by gold standard science from randomized trials published in top medical journals like the American Medical Association Psychiatry journal," Dr. Clarke notes.

The conference will be held from 12 p.m. MDT Sunday, Sept. 28, to 5 p.m. on Tuesday, Sept. 30 at the Boulder Jewish Community Center, located at 6007 Oreg Ave., Boulder, CO 80303. For media passes, contact info@symptomatic.me.

About Dr. David Clarke: Dr. David Clarke is the President of the Association for the Treatment of Neuroplastic Symptoms (ATNS), a 501(c)(3) nonprofit dedicated to ending the chronic pain epidemic. Dr. Clarke holds an MD from the University of Connecticut School of Medicine, and is Board-certified in Internal Medicine and Gastroenterology. He is host of the podcast "The Story Behind the Symptoms." His organization's mission is to advance the awareness, diagnosis, and treatment of stress-related, brain-generated medical conditions. Learn more at Symptomatic.Me.

Online press kit: davidclarke.onlinepresskit247.com.

For more information or interview requests, contact Executive Publicist Michelle Tennant Nicholson at Michelle@WasabiPublicity.com or 828-749-3200.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.